Single Ascending Dose of GAP-134 as a 24-hour IV Infusion in Healthy Japanese Males
Clinical trial NCT00543946 · COMPLETED
Trial details
- NCT number
- NCT00543946
- Sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2007-10-01
- Primary completion
- 2008-03-01
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.